CDRH/DHC Webinar Survey

Generic Clearance for the Collection of Qualitative Feedback on Food and Drug Administration Service Delivery

0697--Qualitative Feedback GenIC--CDRH DHC Webinar Survey--Questions--2018

CDRH/DHC Webinar Survey

OMB: 0910-0697

Document [doc]
Download: doc | pdf



Webinar Questions

Thank you taking the time to provide us with feedback about the CDRH webinar program.  Your feedback is greatly appreciated.



  1. Did you attend the most recent webinar, titled [Insert webinar title]

    1. Yes, I attended in real time

    2. I watched the recording after the conclusion of the live webinar

    3. No, but I read the slides or transcript

    4. No

  2. How did you hear about the [Insert webinar title] webinar?

    1. FDA email

    2. FDA phone call

    3. FDA webpage

    4. FDA Tweet/Facebook post

    5. Other

I



f you selected “Other,” please indicate how you heard about the [Insert webinar title] webinar



  1. On a scale of 1-3, how would you rate your familiarity of the topic associated with the webinar [Insert webinar title] before attending the webinar?

  1. Not familiar at all

  2. I am familiar with the topic, but I do not consider myself an expert on the topic.

  3. I am extremely familiar with the topic and would consider myself an expert on the topic

  1. Did you read the guidance document associated with the webinar presentation?

    1. Yes, I read the guidance before the webinar presentation

    2. Yes, I read the guidance after the webinar presentation

    3. No

  2. On a scale of 1-5, how adequate was the length of the presentation for this topic?

  1. The length of the presentation was too short

  2. The length of the presentation was somewhat short

  3. The length of the presentation was just right

  4. The length of the presentation was somewhat long

  5. The length of the presentation was too long

  1. On a scale of 1-3, how would you rate the clarity of the information presented during the webinar [Insert webinar title]?

  1. The information provided was not clear at all

  2. The information provided was somewhat clear

  3. The information provided was very clear

  1. On a scale of 1-3, how would you rate the quality of the Q&A portion of the presentation?

  1. The Q&A portion of the presentation was poor

  2. The Q&A portion of the presentation good

  3. The Q&A portion of the presentation was excellent

  1. On a scale of 1-3, how would you rate the audio and visual quality of the presentation?

  1. The audio and visual quality of the presentation was poor

  2. The audio and visual quality of the presentation was good

  3. The audio and visual quality of the presentation was excellent

  1. On a scale of 1-3, how would you rate the ease of the login process of the webinar?

  1. The login process for the webinar was difficult

  2. The login process for the webinar was moderately easy

  3. The login process for the webinar was easy

  1. Did you visit the FDA Webinars webpage after the conclusion of the [Insert webinar title] webinar?

    1. Yes

    2. No

  2. Would you attend another CDRH Webinar?

    1. Yes

    2. No

  3. If offered, would you be interested in obtaining CE credits from the FDA for attending a webinar such as the one you just recently attended?

  4. Overall, were you satisfied with the CDRH webinar?

    1. Yes

    2. No

P



lease provide comments to further explain any of your responses







File Typeapplication/msword
AuthorAihie, Irene
Last Modified BySYSTEM
File Modified2018-03-28
File Created2018-03-28

© 2024 OMB.report | Privacy Policy